Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07097337Recruiting

Point of Care Fibrinogen Measurement in Trauma Patients in the Emergency Department

Role: collaborator

NCT06480994Recruiting

Exclusion of Venous Thrombo-Embolism With a New Clinical Decision Support

Role: lead

NCT02856789Completed

Determination of Fibrin Activity in Plasma on STA-R® Prototype

Role: lead

NCT02552381Completed

Evaluation of Fibrin Structure Marker in Cancer Patients Treated and Not Treated With LMWH

Role: lead

NCT02438462Completed

Soluble Fibrin for Diagnosing Pulmonary Embolism

Role: lead

NCT02523937Completed

Evaluation of Soluble Fibrin in Thrombosis Exclusion

Role: lead

All 6 trials loaded